Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVVY for HIV prevention in Ghana
NCT00129532Phase 3Unknown
- Sponsor
- biosyn Corporation
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing SAVVY Arm with Placebo Arm (2 arms). Primary endpoint: Combined incidence of HIV-1 and HIV-2 at 12 months. Status: unknown.
02
Drugs
SAVVY vaginal gel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00129532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129532.